Molecular pathobiology of gastric cancer.
Open Access
- 1 December 2006
- journal article
- review article
- Published by SAGE Publications in Scandinavian Journal of Surgery
- Vol. 95 (4), 225-231
- https://doi.org/10.1177/145749690609500403
Abstract
Gastric carcinogenesis is a multistep process, during which numerous genetic and epigenetic alterations accumulate: there are abnormalities of growth factors/receptors, angiogenic factors, cell cycle regulators, DNA mismatch repair genes etc. These abnormalities define, at the same time, the biological character of the cancer cell and may thus serve as therapeutic targets. Genetic instability may cause accumulation of genetic abnormalities. The most important epigenetic alterations are DNA methylation, histone modification and chromatin remodeling. Some of these changes are common in gastric cancer, regardless of subtype, and some differ by histological type or (gastric or intestinal) mucin phenotype. Genetic polymorphism is a crucial endogenous cause and fundamental aspect of cancer risk. Importantly, genetic polymorphisms are also associated with the therapeutic efficacy and toxicity of anti-cancer drugs. Genomic science and technology such as Serial Analysis of Gene Expression (SAGE) allows the identification of novel genes and molecules specifically up-regulated or down-regulated in gastric cancer, e.g., RegIV and claudin-18 can be identified. Advances in our understanding of the genetic and molecular bases lead to improved diagnosis, personalised medicine and prevention of gastric cancer.Keywords
This publication has 17 references indexed in Scilit:
- The New Era in Cancer ResearchScience, 2006
- Accumulation of DNA methylation is associated with tumor stage in gastric cancerCancer, 2006
- Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotypeThe Journal of Pathology, 2006
- Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancerOncogene, 2005
- Expression and localization of Reg IV in human neoplastic and non‐neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinomaThe Journal of Pathology, 2005
- Molecular-pathological prognostic factors of gastric cancer: a reviewGastric Cancer, 2005
- Histone H3 acetylation is associated with reduced p21WAF1/CIP1 expression by gastric carcinomaThe Journal of Pathology, 2004
- Oncogenic mechanisms of the Helicobacter pylori CagA proteinNature Reviews Cancer, 2004
- Gene Expression Profile of Gastric CarcinomaCancer Research, 2004
- Genetic susceptibility and gastric cancer riskInternational Journal of Cancer, 2002